Literature DB >> 2310156

Erythrocyte membrane stearic acid: oleic acid ratios in colorectal cancer using tube capillary column gas liquid chromatography.

J P Neoptolemos1, B S Thomas.   

Abstract

Erythrocyte fatty acids were measured in 32 patients with colorectal cancer (four with recurrent disease), four patients with large colorectal adenomas, and 42 hospitalised patients without cancer. No significant differences were found with respect to any of the fatty acids between these groups. In particular there was no difference between the erythrocyte stearic acid: oleic acid ratios (mean +/- SD) between the cancer cases (1.07 +/- 0.31) and the control cases (1.09 +/- 0.31, 2-tailed Mann-Whitney U test). No difference in this ratio was observed with respect to age or sex and in the case of colorectal cancer, to the Dukes' stage, degree of tumour differentiation, or recurrence. A significant correlation was found between stearic acid concentrations in plasma and erythrocytes from fasting individuals (r = 0.477, n = 24, P less than 0.05). This study provides further evidence that the erythrocyte stearic acid: oleic acid ratio is of no value for diagnosing primary or recurrent colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310156     DOI: 10.1177/000456329002700108

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  3 in total

1.  Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer.

Authors:  J P Neoptolemos; D Husband; C Imray; S Rowley; N Lawson
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

Review 2.  Arachidonic acid and cancer risk: a systematic review of observational studies.

Authors:  Mai Sakai; Saki Kakutani; Chika Horikawa; Hisanori Tokuda; Hiroshi Kawashima; Hiroshi Shibata; Hitomi Okubo; Satoshi Sasaki
Journal:  BMC Cancer       Date:  2012-12-19       Impact factor: 4.430

3.  Reduced tumour growth of the human colonic cancer cell lines COLO-320 and HT-29 in vivo by dietary n-3 lipids.

Authors:  M Sakaguchi; S Rowley; N Kane; C Imray; A Davies; C Jones; M Newbold; M R Keighley; P Baker; J P Neoptolemos
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.